MedPath

ELECTROLYTE STATE & OUTCOME IN SEVERE COVID-19 DISEASE

Not Applicable
Conditions
Health Condition 1: U071- COVID 19 virus identified
Registration Number
CTRI/2023/06/053513
Lead Sponsor
The Dean, GMCHA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Male & female patients confirmed by the real-time PCR/Rapid antigen test on the respiratory tract samples as positive of SARS-CoV-2

2. Patients hospitalized in dedicated Covid-19 intensive care unit.

Exclusion Criteria

1. Patients who had other causes of electrolyte disturbance

2. Chronic organ dysfunction (e.g., hepatic or renal dysfunction),

3. Terminal cancer immunodeficiency

4. Patients with a history of long-term use of hormones & diuretics

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Correlation between the level of the electrolyte disturbances and the morbidity and mortality in patients hospitalized in intensive care unit with severe Covid -19 diseaseTimepoint: 1. Discharge from intensive care unit <br/ ><br>2. Death
Secondary Outcome Measures
NameTimeMethod
-Acid base disturbances on admission & outcome <br/ ><br>Prognostic factors associated with disease progression & mortality risk <br/ ><br>-clinical course & outcomeTimepoint: 1. Discharge from intensive care unit <br/ ><br>2. Death
© Copyright 2025. All Rights Reserved by MedPath